Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin‐dependent kinase inhibitor p27Kip1 gene
Open Access
- 27 September 2005
- journal article
- Published by Wiley in FEBS Letters
- Vol. 579 (25) , 5535-5541
- https://doi.org/10.1016/j.febslet.2005.08.084
Abstract
The effects of progesterone derivatives on breast cancer development are still controversial, probably accounting for their biphasic, opposed effects on mammary cell‐cycle regulation. Here, we demonstrate in vitro that the growth‐inhibitory effects of progesterone on breast cancer T‐47D cells require the transcriptional upregulation of the cyclin‐dependent kinase inhibitor p27Kip1 (p27) gene. A statistical analysis of human tumor biopsies further indicates that p27 mRNA levels correlate to progesterone receptor (PR) levels. Moreover, p27 gene expression is inversely associated with tumor aggressiveness, and is a prognostic factor of favorable disease outcome. Thus, progesterone derivatives selectively activating the p27 gene promoter could be promising drugs against breast cancer progression.Keywords
This publication has 30 references indexed in Scilit:
- TReP-132 Controls Cell Proliferation by Regulating the Expression of the Cyclin-Dependent Kinase Inhibitors p21WAF1/Cip1 and p27Kip1Molecular and Cellular Biology, 2005
- p27Kip1 Expression and grading of breast cancer diagnosed on cytological samplesDiagnostic Cytopathology, 2004
- BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1Oncogene, 2002
- Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation gradeThe Journal of Pathology, 2001
- Aberrant p27Kip1 promoter methylation in malignant melanomaOncogene, 2000
- 5-Benzylidene 1,2-Dihydrochromeno[3,4-f]quinolines, A Novel Class of Nonsteroidal Human Progesterone Receptor AgonistsJournal of Medicinal Chemistry, 1998
- Progesterone Regulates Transcription of the p21 Cyclindependent Kinase Inhibitor Gene through Sp1 and CBP/p300Journal of Biological Chemistry, 1998
- Physiological Action of Progesterone in Target TissuesEndocrine Reviews, 1997
- Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27Science, 1995
- Prognostic value of estrogen and progesterone receptors in primary breast cancerBreast Cancer Research and Treatment, 1983